GEOVAX LABS, INC. Retained Earnings
GEOVAX LABS, INC. (GOVX) had Retained Earnings of -$160.51 million as of 2026-06-30, per its S-1 filed 2026-09-17.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-09-17
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$160.51M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$156.08M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$150.82M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$146.40M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$160.51M S-1 · filed 2026-09-17 |
| 2026-03-31 | -$156.08M 10-Q · filed 2026-05-14 |
| 2025-12-31 | -$150.82M S-1 · filed 2026-09-17 |
| 2025-09-30 | -$146.40M 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$140.08M 10-Q · filed 2025-07-28 |
| 2025-03-31 | -$134.71M 10-Q · filed 2025-05-01 |
| 2024-12-31 | -$129.36M S-1 · filed 2026-09-17 |
| 2024-09-30 | -$121.09M 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$115.28M 10-Q · filed 2024-08-06 |
| 2024-03-31 | -$110.21M 10-Q · filed 2024-05-14 |
| 2023-12-31 | -$104.36M 10-K · filed 2025-03-27 |
| 2023-09-30 | -$96.77M 10-Q · filed 2023-11-08 |
| 2023-06-30 | -$88.36M 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$82.43M 10-Q · filed 2023-05-04 |
| 2022-12-31 | -$78.40M 10-K · filed 2024-02-29 |
| 2022-09-30 | -$73.01M 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$69.05M 10-Q · filed 2022-08-03 |
| 2022-03-31 | -$66.80M 10-Q · filed 2022-04-27 |
| 2021-12-31 | -$64.38M 10-K · filed 2023-03-23 |
| 2021-09-30 | -$50.63M 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$48.68M 10-Q · filed 2021-08-11 |
| 2021-03-31 | -$47.37M 10-Q · filed 2021-05-06 |
| 2020-12-31 | -$45.81M 10-K · filed 2022-03-09 |
| 2020-09-30 | -$44.47M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$43.90M 10-Q · filed 2020-08-10 |
| 2020-03-31 | -$43.44M 10-Q · filed 2020-05-05 |
| 2019-12-31 | -$42.85M 10-K · filed 2021-03-23 |
| 2019-09-30 | -$42.26M 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$41.83M 10-Q · filed 2019-08-13 |
| 2019-03-31 | -$41.18M 10-Q · filed 2019-05-13 |
| 2018-12-31 | -$40.48M 10-K · filed 2020-03-24 |
| 2018-09-30 | -$39.84M 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$39.18M 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$38.54M 10-Q · filed 2018-05-03 |
| 2017-12-31 | -$37.92M 10-K · filed 2019-03-26 |
| 2017-09-30 | -$37.40M 10-Q · filed 2017-11-09 |
| 2017-06-30 | -$36.81M 10-Q · filed 2017-08-14 |
| 2017-03-31 | -$36.29M 10-Q · filed 2017-05-12 |
| 2016-12-31 | -$35.75M 10-K · filed 2018-03-23 |
| 2016-09-30 | -$34.81M 10-Q · filed 2016-11-14 |
| 2016-06-30 | -$34.35M 10-Q · filed 2016-08-05 |
| 2016-03-31 | -$33.77M 10-Q · filed 2016-05-04 |
| 2015-12-31 | -$32.47M 10-K · filed 2017-03-24 |
| 2015-09-30 | -$31.78M 10-Q · filed 2015-11-12 |
| 2015-06-30 | -$31.16M 10-Q · filed 2015-08-04 |
| 2014-12-31 | -$29.79M 10-K · filed 2016-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |